Aspen Pharmacare Limited (APNHF)

PNK: APNHF · Real-Time Price · USD

12.24

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

Aspen Pharmacare Income Statement

Financials in ZAR. Fiscal year is July - June.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Jun 30, 2018	Dec 30, 2017	Jun 30, 2017	Dec 30, 2016	Jun 30, 2016	Dec 30, 2015
Revenue	23.27B	20.98B	21.34B	18.88B	19.05B	19.27B	19.13B	18.59B	19.84B	18.62B	19.3B	19.16B	19.16B	20.61B	20.61B	17.8B	17.8B
Cost of Revenue	13.26B	11.74B	11.47B	10.04B	10.49B	10.2B	10.8B	9.75B	10.43B	9.4B	10.01B	9.31B	9.31B	10.66B	10.66B	8.85B	8.85B
Gross Profit	10.02B	9.24B	9.87B	8.84B	8.56B	9.07B	8.33B	8.84B	9.41B	9.23B	9.3B	9.84B	9.84B	9.95B	9.95B	8.95B	8.95B
Operating Income	3.5B	4.28B	5.11B	4.28B	4.34B	4.81B	3.97B	4.69B	5.07B	4.7B	4.41B	4.25B	4.25B	4.16B	4.16B	4.5B	4.5B
Interest Income	583.66M	464.33M	460.21M	63.11M	44.59M	59.65M	86.01M	53.89M	75.5M	79.89M	171.94M	91M	91M	129.5M	129.5M	150M	150M
Pretax Income	1.4B	2.89B	3.22B	3.25B	3.9B	4.17B	3.17B	2.82B	2.58B	3B	-703.86M	3.37B	3.37B	3.13B	3.13B	3.05B	3.05B
Net Income	1.04B	2.3B	2.53B	2.64B	3.1B	3.34B	2.15B	2.25B	2.15B	2.7B	-824.52M	3.02B	3.02B	2.56B	2.56B	2.15B	2.15B
Selling & General & Admin	5.08B	4.96B	4.76B	4.56B	4.21B	4.26B	4.36B	4.16B	4.34B	4.53B	4.89B	2.54B	2.54B	2.76B	2.76B	2.4B	2.4B
Research & Development	81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	55.5M	55.5M	94M	94M	100M	100M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.61B	4.96B	4.76B	4.56B	4.21B	4.26B	4.36B	4.16B	4.34B	4.53B	4.89B	4.91B	4.91B	5.07B	5.07B	3.85B	3.85B
Interest Expense	620.13M	951.49M	820.47M	324.41M	250.71M	381.75M	502.05M	537.86M	736.4M	697.77M	1.14B	1.08B	1.08B	1.08B	1.08B	1B	1B
Selling & Marketing Expenses	3.33B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.73B	1.73B	2.04B	2.04B	1.7B	1.7B
Cost & Expenses	20.07B	16.7B	16.23B	14.6B	14.71B	14.46B	15.16B	13.91B	14.77B	13.92B	14.89B	14.23B	14.23B	15.73B	15.73B	12.7B	12.7B
Income Tax Expense	358M	589.35M	695.76M	615.3M	804.64M	829.11M	645.06M	544.85M	446.15M	542.04M	174.96M	561M	561M	562M	562M	900M	900M
Shares Outstanding (Basic)	444.12M	444.3M	444.24M	444.2M	450.7M	456.5M	455.16M	456.5M	455.52M	456.5M	455.8M	456.4M	456.4M	456.4M	456.4M	456.4M	456.4M
Shares Outstanding (Diluted)	444.1M	444.3M	444.24M	444.2M	450.7M	456.5M	455.16M	456.5M	455.52M	456.5M	455.8M	456.4M	456.4M	456.4M	456.4M	456.5M	456.5M
EPS (Basic)	2.35	5.09	5.61	5.89	6.82	7.31	4.71	4.98	4.77	5.94	-1.84	6.62	6.62	5.62	5.62	4.72	4.72
EPS (Diluted)	2.35	5.09	5.61	5.89	6.82	7.31	4.71	4.98	4.77	5.94	-1.84	6.62	6.62	5.62	5.62	4.72	4.72
EBITDA	5.86B	5.22B	6.03B	5.13B	5.2B	5.66B	4.78B	5.52B	4.15B	4.44B	1.02B	5.14B	5.14B	4.84B	4.84B	5.25B	5.25B
EBIT	2.7B	211.14M	216.15M	212.54M	255.77M	286.58M	256.88M	228.88M	194.76M	261.67M	30.42M	4.45B	4.45B	4.2B	4.2B	4.05B	4.05B
Depreciation & Amortization	232.5M	936.6M	918.45M	848.01M	853.2M	847.01M	803.08M	832.24M	828.57M	744.29M	589.23M	686M	686M	633.5M	633.5M	600M	600M